Sickle cell disease: More than a century of progress. Where do we stand now?

[1] Savitt TL, Goldberg MF., Herrick?s 1910 case report of sickle cell anemia. The rest of the story, JAMA, 261, pp. 266-271, (1989)

[2] Kato GJ, Piel FB, Reid CD, Gaston MH, Ohene-Frempong K, Krishnamurti L, Et al., Sickle cell disease, Nat Rev Dis Primers, 4, (2018)

[3] Panepinto JA., Health-related quality of life in patients with hemoglobinopathies, Hematology Am Soc Hematol Educ Program, 2012, pp. 284-289, (2012)

[4] Piel FB, Patil AP, Howes RE, Nyangiri OA, Gething PW, Dewi M, Et al., Global epidemiology of sickle haemoglobin in neonates: A contemporary geostatistical model-based map and population estimates, Lancet, 381, pp. 142-151, (2013)

[5] Hockham C, Bhatt S, Colah R, Mukherjee MB, Penman BS, Gupta S, Et al., The spatial epidemiology of sickle-cell anaemia in India, Sci Rep, 8, (2018)

[6] Jain D, Mohanty D., Clinical manifestations of sickle cell disease in India: Misconceptions and reality, Curr Opin Hematol, 25, pp. 171-176, (2018)

[7] Jain D, Arjunan A, Sarathi V, Jain H, Bhandarwar A, Vuga M, Et al., Clinical events in a large prospective cohort of children with sickle cell disease in Nagpur, India: Evidence against a milder clinical phenotype in India, Pediatr Blood Cancer, 63, pp. 1814-1821, (2016)

[8] Quinn CT, Rogers ZR, McCavit TL, Buchanan GR., Improved survival of children and adolescents with sickle cell disease, Blood, 115, pp. 3447-3452, (2010)

[9] Grosse SD, Odame I, Atrash HK, Amendah DD, Piel FB, Williams TN., Sickle cell disease in Africa: A neglected cause of early childhood mortality, Am J Prev Med, 41, 6, pp. S398-S405, (2011)

[10] Saxena D, Yasobant S, Golechha M., Situational analysis of sickle cell disease in Gujarat, India, Indian J Community Med, 42, pp. 218-221, (2017)

[1] Savitt TL, Goldberg MF., Herrick?s 1910 case report of sickle cell anemia. The rest of the story, JAMA, 261, pp. 266-271, (1989)

[2] Kato GJ, Piel FB, Reid CD, Gaston MH, Ohene-Frempong K, Krishnamurti L, Et al., Sickle cell disease, Nat Rev Dis Primers, 4, (2018)

[3] Panepinto JA., Health-related quality of life in patients with hemoglobinopathies, Hematology Am Soc Hematol Educ Program, 2012, pp. 284-289, (2012)

[4] Piel FB, Patil AP, Howes RE, Nyangiri OA, Gething PW, Dewi M, Et al., Global epidemiology of sickle haemoglobin in neonates: A contemporary geostatistical model-based map and population estimates, Lancet, 381, pp. 142-151, (2013)

[5] Hockham C, Bhatt S, Colah R, Mukherjee MB, Penman BS, Gupta S, Et al., The spatial epidemiology of sickle-cell anaemia in India, Sci Rep, 8, (2018)

[6] Jain D, Mohanty D., Clinical manifestations of sickle cell disease in India: Misconceptions and reality, Curr Opin Hematol, 25, pp. 171-176, (2018)

[7] Jain D, Arjunan A, Sarathi V, Jain H, Bhandarwar A, Vuga M, Et al., Clinical events in a large prospective cohort of children with sickle cell disease in Nagpur, India: Evidence against a milder clinical phenotype in India, Pediatr Blood Cancer, 63, pp. 1814-1821, (2016)

[8] Quinn CT, Rogers ZR, McCavit TL, Buchanan GR., Improved survival of children and adolescents with sickle cell disease, Blood, 115, pp. 3447-3452, (2010)

[9] Grosse SD, Odame I, Atrash HK, Amendah DD, Piel FB, Williams TN., Sickle cell disease in Africa: A neglected cause of early childhood mortality, Am J Prev Med, 41, 6, pp. S398-S405, (2011)

[10] Saxena D, Yasobant S, Golechha M., Situational analysis of sickle cell disease in Gujarat, India, Indian J Community Med, 42, pp. 218-221, (2017)